ACVA three-lens brief
Evidence-based stock research on ACVA. Three independent lenses — Foundation, Expansion, Climate — examine live data from SEC filings, the Federal Reserve, and market feeds. Every claim traces to its primary source.
Performance
Moved -2.04% yesterday. · Underperforming SPY by 14.4pp over 30 days.
- Moved -2.04% yesterday.
- Underperforming SPY by 14.4pp over 30 days.
- Currently unprofitable on a trailing basis — no P/E multiple available.
- Analyst mean target $9.77 — 35% above current (11 analysts).
ACVA closed at $7.22 (-2.04%) as of 2026-09-11. Market cap: $1.26B. Price is below the 50-day MA and above the 200-day MA. Positives: analyst mean target $9.77 — 35% above current (11 analysts).. Concerns: moved -2.04% yesterday.; underperforming SPY by 14.4pp over 30 days.. Last quarter: Revenue $213.94M, net income -$8.23M, free cash flow $857.4K.
Why three lenses on ACVA, not one.
A single reasoning model has blind spots it doesn’t know about. We examine ACVAacross Foundation (fundamentals), Expansion (growth runway and market expansion), and Climate (macro/sector). Disagreement between lenses is surfaced, not hidden — it’s how you know when HOLD is the honest call.
Read the full methodologyDrop it in your newsletter or blog.
Free to embed. Updates every 6 hours. Links back to the full brief.
<iframe src="https://clearpathinvest.app/embed/ACVA" width="100%" height="420" frameborder="0" loading="lazy" title="ClearPath ACVA brief"></iframe>